Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.

1 September 2024 (17:30 - 17:45)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Laust Dupont Rasmussen

Regional Hospital Godstrup, Herning (Denmark)

3 More presentations in this session

Presentation thumbnail

Long-term effect of biodegradable versus durable polymer drug-eluting stents on neoatherosclerosis among STEMI patients: the international CONNECT randomized controlled intracoronary OCT trial

Doctor J. Haener (Bern, CH)

Presentation thumbnail

Glycoprotein IIb/IIIa Inhibitors in patients with acute myocardial infarction and angiographic no-reflow: the randomized REVERSE-FLOW trial

Professor I. Eitel (Luebeck, DE)

Presentation thumbnail

Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome. A randomized trial.

Doctor J. De La Torre Hernandez (Santander, ES)

Access the full session

Session thumbnail

Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation

The Event

Event poster

ESC Congress 2024

1 September 2024 17:30 CET

You may be interested in

Congress Presentation

Prognostic implications of microvascular resistance reserve in symptomatic patients with intermediate coronary stenosis

Congress Session

Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation

Congress Session

Coronary physiology and microcirculatory assessment

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources